Cite
MLA Citation
S. Rahmati et al.. “OP0305 RHO-GTPASE PATHWAYS MAY DIFFERENTIATE RESPONDER AND NON-RESPONDERS TO TUMOUR NECROSIS FACTOR INHIBITOR (TNFI) AND INTERLEUKIN-17A INHIBITOR (IL-17AI) THERAPY IN PSORIATIC ARTHRITIS (PSA).” Annals of the rheumatic diseases, vol. 79, n.d., p. 189. http://access.bl.uk/ark:/81055/vdc_100144720604.0x00004a